Concourse Financial Group Securities’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 3149 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 4580 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 4569 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 4610 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 4613 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 4553 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 4493 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 4428 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 4310 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 4280 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 4082 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 4126 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 4070 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 4152 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 4076 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 3959 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 3872 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 3787 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 3633 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 3533 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 3540 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 3495 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 3234 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 3526 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 3494 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 3375 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 2990 |
|